Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

63.9K
Overview
63.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-species transcriptomic evidence for peripheral-central immune crosstalk in atopic dermatitis.

Frontiers in immunology·2026
Same author

Type 2 Inflammatory Diseases: The Crossroads of Immunity and Metabolism.

Research (Washington, D.C.)·2026
Same author

Atypical signaling, ligand recognition and selective agonist discovery of complement receptor C5aR2.

Cell research·2026
Same author

Leptin in metabolic-immune crosstalk: Mechanisms of T cell regulation and implications for autoimmune disease therapy.

International reviews of immunology·2026
Same author

Delayed identification and treatment of a cervicomedullary spinal vascular lesion following angiogram-negative, high-grade subarachnoid hemorrhage: illustrative case.

Journal of neurosurgery. Case lessons·2026
Same author

Evaluating the Risk of <i>Clostridioides difficile</i> Infection After Rifaximin Treatment for Small Intestinal Bacterial Overgrowth.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Apr 22, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.6K

Cell-based therapies for systemic lupus erythematosus.

Jieyue Liao, Christopher Chang, Haijing Wu

    Autoimmunity Reviews
    |October 14, 2014
    PubMed
    Summary

    New cell-based therapies show promise for treating systemic lupus erythematosus (SLE), offering a safer alternative to current treatments. These innovative approaches aim for long-term disease suppression or a potential cure for SLE patients.

    More Related Videos

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
    10:10

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

    Published on: November 8, 2016

    8.1K
    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
    05:32

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

    Published on: February 16, 2024

    1.1K

    Related Experiment Videos

    Last Updated: Apr 22, 2026

    The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
    12:04

    The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

    Published on: November 1, 2015

    17.6K
    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
    10:10

    Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

    Published on: November 8, 2016

    8.1K
    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
    05:32

    In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

    Published on: February 16, 2024

    1.1K

    Area of Science:

    • Immunology
    • Autoimmune Diseases
    • Cell Therapy

    Background:

    • Systemic lupus erythematosus (SLE) is a complex autoimmune disease predominantly affecting females, leading to multi-organ dysfunction.
    • Current treatments like corticosteroids and immunosuppressants have significant adverse effects.
    • There is a critical need for safer and more effective SLE therapies.

    Purpose of the Study:

    • To provide an overview of emerging cell-based therapeutic strategies for SLE.
    • To highlight pre-clinical and clinical research on novel cell therapies for SLE.
    • To discuss the potential of cell-based approaches for long-term SLE management.

    Main Methods:

    • Review of current scientific literature on cell-based therapies for SLE.
    • Analysis of pre-clinical and clinical trial data for various immunoregulatory cells.
    • Focus on therapies involving regulatory T cells, mesenchymal stem cells, B-cells, and natural killer cells.

    Main Results:

    • Cell-based therapies are an emerging area of interest for SLE treatment.
    • Several immunoregulatory cell types are being investigated for their therapeutic potential.
    • These novel therapies aim to promote immune tolerance and offer a potential cure.

    Conclusions:

    • Cell-based therapies represent a promising frontier in SLE treatment, potentially overcoming limitations of conventional therapies.
    • Further research and clinical trials are essential to establish the efficacy and safety of these novel approaches.
    • The development of tolerance-promoting cell therapies could revolutionize SLE management.